Results 101 to 110 of about 367 (113)

Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.

Antimicrobial Agents and Chemotherapy, 2021
Xingdang Liu, Yuancheng Chen, Guoying Cao   +2 more
exaly  

People also looked at

Frontiers in Microbiology, 2021
Chang Cai, Shufang Zheng, Yingbo Shen
exaly  

Top bar navigation

Frontiers in Pharmacology, 2023
Xin-Yi Yang, Jufang Wu, Hailan Wu
exaly  

Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections.

Antimicrobial Agents and Chemotherapy, 2022
Yuancheng Chen, Guoying Cao, Beining Guo
exaly  

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report

Infection and Drug Resistance, 2023
Pengzhi Chen
exaly  

Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis.

Antimicrobial Agents and Chemotherapy, 2022
Qingyun Liu, Qian Gao
exaly  

A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro.

Antimicrobial Agents and Chemotherapy, 2021
Haiqing Chu, Zhemin Zhang, Liyun Xu
exaly  

Severe Community-Acquired Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus: Successfully Treated with Contezolid – A Case Report and Literature Review

Infection and Drug Resistance, 2023
Zhimei Duan
exaly  

A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects.

Antimicrobial Agents and Chemotherapy, 2023
Jing Zhang
exaly  

Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis

Clinical Therapeutics, 2019
Demei Zhu, Fupin Hu, Yuancheng Chen
exaly